…
Presidio is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties. Presidio's model homes are leased to homebuilders located in Arizona, Illinois, Texas, Wisconsin, and Florida. Our office, industrial and retail properties are located primarily in Colorado, with properties also located in Maryland, North Dakota, Texas, and Southern California. While geographical clustering of real estate enables us to reduce our operating costs through economies of scale by servicing several properties with less staff, it makes us susceptible to changing market conditions in these discrete geographic areas, including those that have developed as a result of COVID-19. Presidio owns approximately 6.5% of the outstanding common stock of Conduit Pharmaceuticals Inc., a disease agnostic multi-asset clinical-stage disease-agnostic life science company providing an efficient model for compound development.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Income before tax | 2.70M | -1.51M | -5.89M | 1.38M | 4.97M |
| Minority interest | -3.61M | -2.16M | -1.41M | -1.38M | -1.07M |
| Net income | 1.49M | -1.46M | -6.26M | 0.77M | 3.38M |
| Selling general administrative | 6.16M | 6.23M | 5.75M | 5.27M | 4.53M |
| Gross profit | 11.92M | 13.05M | 15.53M | 18.23M | 21.46M |
| Reconciled depreciation | 5.47M | 5.38M | 6.15M | 7.23M | 8.28M |
| Ebit | 2.33M | 1.42M | 2.98M | 5.87M | 7.20M |
| Ebitda | 7.80M | 6.82M | 9.25M | 13.10M | 15.47M |
| Depreciation and amortization | 5.47M | 5.40M | 6.27M | 7.23M | 8.28M |
| Operating income | 2.33M | 1.42M | 2.98M | 5.87M | 7.82M |
| Other operating expenses | 17.47M | 17.81M | 20.84M | 23.04M | 24.52M |
| Interest expense | 4.71M | 4.83M | 8.83M | 10.65M | 13.04M |
| Tax provision | 1.22M | -0.05M | 0.37M | 0.61M | 0.52M |
| Interest income | 2.04M | - | - | 0.14M | 0.06M |
| Net interest income | -2.67M | -4.83M | -8.83M | -10.51M | -12.99M |
| Income tax expense | 1.22M | -0.05M | 0.37M | 0.61M | 0.52M |
| Total revenue | 17.76M | 19.23M | 24.35M | 28.64M | 32.34M |
| Total operating expenses | 11.63M | 11.62M | 12.03M | 12.63M | 13.63M |
| Cost of revenue | 5.84M | 6.18M | 8.82M | 10.41M | 10.89M |
| Total other income expense net | 0.37M | -2.94M | -8.87M | -4.49M | 10.13M |
| Net income from continuing ops | 1.49M | -1.46M | -6.26M | 0.77M | 4.45M |
| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total assets | 175.96M | 291.35M | 161.20M | 185.57M | 220.78M |
| Intangible assets | 4.11M | 3.24M | 4.11M | 4.11M | 5.53M |
| Other current assets | -9.50M | -2.03M | -2.38M | -2.77M | 0.60M |
| Total liab | 114.66M | 108.10M | 95.71M | 135.45M | 164.16M |
| Total stockholder equity | 50.93M | 174.24M | 55.67M | 34.88M | 39.18M |
| Other current liab | 2.13M | 2.06M | 2.12M | 2.55M | 2.99M |
| Common stock | 0.12M | 130.53M | 0.12M | 0.10M | 0.18M |
| Capital stock | 0.13M | 130.54M | 0.13M | 0.10M | 0.18M |
| Retained earnings | -131.51M | -138.34M | -130.95M | -121.67M | -113.04M |
| Good will | 1.57M | 2.42M | 2.42M | 2.42M | 2.42M |
| Other assets | - | - | 140.34M | - | - |
| Cash | 6.51M | 16.52M | 14.70M | 11.54M | 10.39M |
| Total current liabilities | 6.92M | 11.13M | 6.71M | 7.67M | 8.66M |
| Current deferred revenue | -23.49M | - | - | - | - |
| Net debt | 101.23M | 80.43M | 74.23M | 116.09M | 144.80M |
| Short term debt | 23.49M | - | 177.80M | - | - |
| Short long term debt total | 107.74M | 96.95M | 88.94M | 127.63M | 155.19M |
| Other stockholder equity | 313.82M | 182.04M | 186.49M | 156.46M | 152.04M |
| Total current assets | 14.96M | 18.53M | 26.13M | 54.04M | 56.62M |
| Long term investments | 18.36M | 136.87M | - | - | - |
| Short term investments | - | 0.80M | 1.51M | - | - |
| Net receivables | 2.99M | 2.03M | 2.38M | 2.77M | 4.33M |
| Long term debt | 107.71M | 96.90M | 88.86M | 127.53M | 154.63M |
| Inventory | 5.46M | 2.02M | 11.43M | 42.50M | 41.29M |
| Accounts payable | 4.79M | 9.08M | 4.59M | 5.13M | 5.67M |
| Accumulated other comprehensive income | -131.51M | - | - | - | - |
| Non currrent assets other | 136.60M | 130.24M | 128.46M | 124.89M | 155.65M |
| Non current assets total | 161.01M | 272.82M | 135.06M | 131.53M | 164.17M |
| Capital lease obligations | 0.02M | 0.05M | 0.08M | 0.10M | 0.56M |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Investments | -126.38M | 24.20M | 27.68M | 11.98M | 25.59M |
| Total cash from financing activities | 127.26M | -23.42M | -30.22M | -15.16M | -24.56M |
| Net income | 1.49M | -1.46M | -6.26M | 0.77M | 4.45M |
| Change in cash | 1.81M | 3.16M | 1.15M | 0.62M | 1.47M |
| Begin period cash flow | 14.70M | 11.54M | 10.39M | 9.78M | 8.31M |
| End period cash flow | 16.52M | 14.70M | 11.54M | 10.39M | 9.78M |
| Total cash from operating activities | 0.93M | 2.37M | 3.69M | 3.79M | 0.43M |
| Issuance of capital stock | 134.02M | 29.36M | - | - | - |
| Depreciation | 5.41M | 5.38M | 6.15M | 7.23M | 8.28M |
| Dividends paid | -5.27M | -5.47M | -0.96M | -2.16M | 1075.37M |
| Sale purchase of stock | -0.44M | -0.11M | -0.02M | -17.13M | -13.80M |
| Other cashflows from financing activities | 10.90M | 24.03M | -0.26M | 0.33M | 0.11M |
| Capital expenditures | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Change in working capital | -0.13M | -1.64M | -0.28M | 0.16M | -1.92M |
| Stock based compensation | 1.20M | 1.61M | 1.11M | 0.69M | 0.46M |
| Other non cash items | -7.04M | 0.25M | 2.41M | 1.29M | 0.72M |
| Free cash flow | 0.93M | 2.37M | 3.69M | 3.79M | 0.43M |
Sector: Real Estate Industry: REIT - Diversified
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
|---|---|---|---|---|---|---|
| SQFTW Presidio Property Trust Inc. Series A Common Stock Purchase Warrants |
- -% |
0.01 | - | - | - | - |
| GMGSF Goodman Group |
0.10 0.50% |
20.18 | 35.32 | 21.46 | 13.97 | 2.56 |
| VICI VICI Properties Inc |
0.21 0.85% |
25.01 | 13.14 | 11.40 | 9.27 | 1.33 |
| WPC W P Carey Inc |
0.73 1.12% |
65.67 | 23.40 | 25.00 | 8.55 | 1.82 |
| CTOUF Charter Hall Group |
-0.74 4.90% |
14.46 | 19.27 | 20.58 | 8.82 | 3.56 |
Presidio is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties. Presidio's model homes are leased to homebuilders located in Arizona, Illinois, Texas, Wisconsin, and Florida. Our office, industrial and retail properties are located primarily in Colorado, with properties also located in Maryland, North Dakota, Texas, and Southern California. While geographical clustering of real estate enables us to reduce our operating costs through economies of scale by servicing several properties with less staff, it makes us susceptible to changing market conditions in these discrete geographic areas, including those that have developed as a result of COVID-19. Presidio owns approximately 6.5% of the outstanding common stock of Conduit Pharmaceuticals Inc., a disease agnostic multi-asset clinical-stage disease-agnostic life science company providing an efficient model for compound development.
4995 Murphy Canyon Road, San Diego, CA, United States, 92123-4366
760 471 8536
15
| Name | Title | Year Born |
|---|---|---|
| Mr. Jack Kendrick Heilbron | Chairman, Pres & CEO | 1950 |
| Mr. Adam Sragovicz | Chief Financial Officer | 1970 |
| Mr. Gary Morris Katz | Chief Investment Officer | 1963 |
| Mr. Edwin H. Bentzen IV | Chief Accounting Officer | 1977 |
| Mr. Steven Foss | Director of Investor Relations | NA |
| Mr. Sean Giffin | Director of Acquisitions & Asset Management | NA |
| Mr. Steve Hightower | Pres of Model Home Division | NA |
| Mr. Jack Kendrick Heilbron | Chairman, President & CEO | 1950 |
| Mr. Gary Morris Katz | Chief Investment Officer | 1964 |
| Mr. Steve Hightower | President of Model Home Division & Director | 1968 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.